Publication:
Polymorphisms in nitric oxide synthase and endothelin genes among children with obstructive sleep apnea

dc.contributor.authorChatsuriyawong S.
dc.contributor.authorGozal D.
dc.contributor.authorKheirandish-Gozal L.
dc.contributor.authorBhattacharjee R.
dc.contributor.authorKhalyfa A.A.
dc.contributor.authorWang Y.
dc.contributor.authorSukhumsirichart W.
dc.contributor.authorKhalyfa A.
dc.date.accessioned2021-04-05T03:32:49Z
dc.date.available2021-04-05T03:32:49Z
dc.date.issued2013
dc.date.issuedBE2556
dc.description.abstractBackground: Obstructive sleep apnea (OSA) is associated with adverse and interdependent cognitive and cardiovascular consequences. Increasing evidence suggests that nitric oxide synthase (NOS) and endothelin family (EDN) genes underlie mechanistic aspects of OSA-associated morbidities. We aimed to identify single nucleotide polymorphisms (SNPs) in the NOS family (3 isoforms), and EDN family (3 isoforms) to identify potential associations of these SNPs in children with OSA. Methods. A pediatric community cohort (ages 5-10 years) enriched for snoring underwent overnight polysomnographic (NPSG) and a fasting morning blood draw. The diagnostic criteria for OSA were an obstructive apnea-hypopnea Index (AHI) >2/h total sleep time (TST), snoring during the night, and a nadir oxyhemoglobin saturation <92%. Control children were defined as non-snoring children with AHI <2/h TST (NOSA). Endothelial function was assessed using a modified post-occlusive hyperemic test. The time to peak reperfusion (Tmax) was considered as the indicator for normal endothelial function (NEF; Tmax<45 sec), or ED (Tmax≥45 sec). Genomic DNA from peripheral blood was extracted and allelic frequencies were assessed for, NOS1 (209 SNPs), NOS2 (122 SNPs), NOS3 (50 SNPs), EDN1 (43 SNPs), EDN2 (48 SNPs), EDN3 (14 SNPs), endothelin receptor A, EDNRA, (27 SNPs), and endothelin receptor B, EDNRB (23 SNPs) using a custom SNPs array. The relative frequencies of NOS-1,-2, and -3, and EDN-1,-2,-3,-EDNRA, and-EDNRB genotypes were evaluated in 608 subjects [128 with OSA, and 480 without OSA (NOSA)]. Furthermore, subjects with OSA were divided into 2 subgroups: OSA with normal endothelial function (OSA-NEF), and OSA with endothelial dysfunction (OSA-ED). Linkage disequilibrium was analyzed using Haploview version 4.2 software. Results: For NOSA vs. OSA groups, 15 differentially distributed SNPs for NOS1 gene, and 1 SNP for NOS3 emerged, while 4 SNPs for EDN1 and 1 SNP for both EDN2 and EDN3 were identified. However, in the smaller sub-group for whom endothelial function was available, none of the significant SNPs was retained due to lack of statistical power. Conclusions: Differences in the distribution of polymorphisms among NOS and EDN gene families suggest that these SNPs could play a contributory role in the pathophysiology and risk of OSA-induced cardiovascular morbidity. Thus, analysis of genotype-phenotype interactions in children with OSA may assist in the formulation of categorical risk estimates. © 2013 Chatsuriyawong et al.; licensee BioMed Central Ltd.
dc.format.mimetypeapplication/pdf
dc.identifier.citationBMC Medical Genomics. Vol 6, No.1 (2013), p.-
dc.identifier.doi10.1186/1755-8794-6-29
dc.identifier.issn17558794
dc.identifier.other2-s2.0-84883539642
dc.identifier.urihttps://hdl.handle.net/20.500.14740/6552
dc.rights.holderScopus
dc.subject.otherEndothelial nitric oxide synthase
dc.subject.otherEndothelin
dc.subject.otherEndothelin receptor
dc.subject.otherGenomic DNA
dc.subject.otherInducible nitric oxide synthase
dc.subject.otherIsoprotein
dc.subject.otherNeuronal nitric oxide synthase
dc.subject.otherNitric oxide synthase
dc.subject.otherOxyhemoglobin
dc.subject.otherProtein EDNRA
dc.subject.otherProtein EDNRB
dc.subject.otherUnclassified drug
dc.subject.otherApnea hypopnea index
dc.subject.otherArticle
dc.subject.otherBlood analysis
dc.subject.otherChild
dc.subject.otherCohort analysis
dc.subject.otherComputer program
dc.subject.otherControlled study
dc.subject.otherDNA extraction
dc.subject.otherEdn1 gene
dc.subject.otherEDN2 gene
dc.subject.otherEDN3 gene
dc.subject.otherEDNRA gene
dc.subject.otherEDNRB gene
dc.subject.otherEndothelial dysfunction
dc.subject.otherFemale
dc.subject.otherGene
dc.subject.otherGene frequency
dc.subject.otherGene linkage disequilibrium
dc.subject.otherGenetic identification
dc.subject.otherGenotype
dc.subject.otherHuman
dc.subject.otherMajor clinical study
dc.subject.otherMale
dc.subject.otherMultigene family
dc.subject.otherNOS1 gene
dc.subject.otherNos2 gene
dc.subject.otherNOS3 gene
dc.subject.otherOxygen saturation
dc.subject.otherPolysomnography
dc.subject.otherPreschool child
dc.subject.otherPriority journal
dc.subject.otherProtein assembly
dc.subject.otherProtein localization
dc.subject.otherSchool child
dc.subject.otherSingle nucleotide polymorphism
dc.subject.otherSleep disordered breathing
dc.subject.otherSleep time
dc.subject.otherSnoring
dc.subject.otherTime to maximum plasma concentration
dc.subject.otherOsa
dc.subject.otherChild
dc.subject.otherChild, Preschool
dc.subject.otherEndothelins
dc.subject.otherFemale
dc.subject.otherGene Frequency
dc.subject.otherGenetic Predisposition to Disease
dc.subject.otherHumans
dc.subject.otherMale
dc.subject.otherNitric Oxide Synthase
dc.subject.otherPolymorphism, Single Nucleotide
dc.subject.otherPolysomnography
dc.subject.otherSleep Apnea, Obstructive
dc.titlePolymorphisms in nitric oxide synthase and endothelin genes among children with obstructive sleep apnea
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84883539642&doi=10.1186%2f1755-8794-6-29&partnerID=40&md5=34c08555d43480562c5a617b69bd2590

Files